Led by Caroline Huber, Associate Director of Policy and Economics, a surprising new study was recently published in The Journal of Infectious Diseases, estimating the overlooked social, economic and health impacts of the 2013-2016 West Africa Ebola crisis.
Speaking with AIS Health’s Angela Maas, Senior Research Economist Jason Shafrin addresses the Trump Administration’s proposal to establish flat rate prescription reimbursement to physicians—calling out several of the pros and cons.
In the most recent Radar on Specialty Pharmacy, Senior Research Economist Jason Shafrin addresses the Trump Administration’s proposed changes to the International Pricing Index, and how these changes might impact future drug development and innovation.
VETERAN STRATEGIST CHOSEN TO LEAD INNOVATIVE HEALTH ECONOMICS,
MARKET ACCESS, AND PAYER ANALYTICS CONSULTANCY
Bethesda, MD – November 7, 2018 – Precision Xtract, part of Precision Value & Health, today announced Zac Stillerman, acclaimed healthcare industry operator and strategist, as new president and general manager. Responsible for leading Precision Xtract through its next phase of growth, Stillerman has a proven ability to translate vision and strategy into dynamic collaboration and first-class execution. He joins Precision Xtract at a time of growing demand from innovative life sciences companies for essential consulting activities, […]
Payers can face challenges in using appropriate management strategies close to launch. It’s difficult to have a complete picture of a therapy or device when manufacturers hesitate sharing certain information amid unclear FDA regulations. […]
For more information, or to learn how to change your cookies preferences, please click here.